没有肝硬化患者的肝细胞癌
Karina Sato-Espinoza1, Mayra Valdivia-Herrera2, Perapa Chotiprasidhi1
1Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN 55902, United States.
World journal of gastroenterology
|June 27, 2025
概括
肝细胞癌 (HCC) 在没有肝硬化的患者中正在增加,这是由代谢功能障碍相关的脂肪性肝病 (MASLD) 驱动的. 本综述涉及对非肝硬化HCC的有限数据,指导改进诊断和治疗.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 肝硬化是主要的风险因素,但非肝硬化HCC正在增加,特别是由于代谢功能障碍相关的脂肪性肝病 (MASLD).
- 对于非肝性HCC存在有限的数据,这阻碍了指导方针的制定.
研究的目的:
- 综合审查非肝性HCC的流行病学,临床和遗传特征,诊断方式和治疗方法.
- 为了解决知识上的差距,并指导为这一患者亚组开发增强的诊断和治疗策略.
- 为非肝硬化HCC.患者的临床管理和监测提供信息.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 对流行病学数据的分析.
- 临床和遗传特征的评估.
- 对诊断和治疗策略的评估.
主要成果:
- 非肝硬化HCC的发病率正在上升,特别是在发达国家,与MASLD的患病率有关.
- 目前的查和诊断标准对于非肝硬化HCC往往是不够的.
- 非肝硬化HCC的治疗策略经常从肝硬化队列中推断出来,需要进一步的研究.
结论:
- 需要加强针对非肝硬化HCC的诊断和治疗策略.
- 需要进一步的研究,以了解非肝性HCC的独特方面,包括其流行病学,遗传学和治疗反应.
- 为改善患者的治疗结果,制定非肝性HCC的具体指导方针至关重要.
更多相关视频
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
36.3K
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.0K
相关概念视频
01:24Liver Regeneration
3.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.4K
01:26Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K